The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization.
Saved in:
| Title: | The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization. |
|---|---|
| Authors: | Hawkins, Kellie L. (AUTHOR), Hojat, Leila S. (AUTHOR), Hicks, Carrie (AUTHOR), McLees, Margaret P. (AUTHOR), Rowan, Sarah (AUTHOR), Burman, William J. (AUTHOR), Gardner, Edward M. (AUTHOR) |
| Source: | AIDS Care. Nov2025, Vol. 37 Issue 11, p1883-1893. 11p. |
| Subjects: | Documentation, Medical protocols, Antiretroviral agents, Data analysis, Creatinine, Drug resistance in microorganisms, Salvage therapy, Body weight, HIV infections, Retrospective studies, Descriptive statistics, Chi-squared test, Mann Whitney U Test, DNA, Highly active antiretroviral therapy, Workflow, Low density lipoproteins, Medical records, Acquisition of data, Electronic health records, Alanine aminotransferase, Social support, Quality assurance, Data analysis software, Genotypes, Drug utilization |
| Abstract: | Contemporary antiretroviral therapy (ART) is well-tolerated, safe and has simple dosing schedules. Here we evaluate a clinic wide initiative that uses detailed ART reviews when switching highly treatment-experienced individuals with or without HIV viremia to new regimens. We hypothesized that viral suppression post-switch would be maintained or improved. Persons who had a comprehensive ART review performed between March 2016 and December 2020 for optimization or virologic failure in an urban HIV clinic were included. Primary outcome was viral suppression at 6 months post-switch, and secondary outcomes included sustained viral suppression at 2 years, ART regimen characteristics and metabolic-associated changes. In patients with suppressed HIV-RNA who optimized therapy, 43 (96%) of 45 remained suppressed at 6 months. Among people switching for virologic failure, 16 (84%) of 19 achieved viral suppression at 6 months. Two years post-switch, 44 (88%) of 50 people were still in care on the optimized regimen and had viral suppression. Multiple different ART regimen characteristics improved as well. The use of ART reviews to assist in regimen recommendations for people with HIV who are highly treatment experienced is safe and effective. HIV clinicians should consider using detailed ART reviews in highly treatment-experienced individuals to facilitate optimization and record this critical medical history. [ABSTRACT FROM AUTHOR] |
| Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 189061864 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hawkins%2C+Kellie+L%2E%22">Hawkins, Kellie L.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hojat%2C+Leila+S%2E%22">Hojat, Leila S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hicks%2C+Carrie%22">Hicks, Carrie</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McLees%2C+Margaret+P%2E%22">McLees, Margaret P.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rowan%2C+Sarah%22">Rowan, Sarah</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burman%2C+William+J%2E%22">Burman, William J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gardner%2C+Edward+M%2E%22">Gardner, Edward M.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22AIDS+Care%22">AIDS Care</searchLink>. Nov2025, Vol. 37 Issue 11, p1883-1893. 11p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Documentation%22">Documentation</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+protocols%22">Medical protocols</searchLink><br /><searchLink fieldCode="DE" term="%22Antiretroviral+agents%22">Antiretroviral agents</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis%22">Data analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Creatinine%22">Creatinine</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+resistance+in+microorganisms%22">Drug resistance in microorganisms</searchLink><br /><searchLink fieldCode="DE" term="%22Salvage+therapy%22">Salvage therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Body+weight%22">Body weight</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+infections%22">HIV infections</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+studies%22">Retrospective studies</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Chi-squared+test%22">Chi-squared test</searchLink><br /><searchLink fieldCode="DE" term="%22Mann+Whitney+U+Test%22">Mann Whitney U Test</searchLink><br /><searchLink fieldCode="DE" term="%22DNA%22">DNA</searchLink><br /><searchLink fieldCode="DE" term="%22Highly+active+antiretroviral+therapy%22">Highly active antiretroviral therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Workflow%22">Workflow</searchLink><br /><searchLink fieldCode="DE" term="%22Low+density+lipoproteins%22">Low density lipoproteins</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+records%22">Medical records</searchLink><br /><searchLink fieldCode="DE" term="%22Acquisition+of+data%22">Acquisition of data</searchLink><br /><searchLink fieldCode="DE" term="%22Electronic+health+records%22">Electronic health records</searchLink><br /><searchLink fieldCode="DE" term="%22Alanine+aminotransferase%22">Alanine aminotransferase</searchLink><br /><searchLink fieldCode="DE" term="%22Social+support%22">Social support</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+assurance%22">Quality assurance</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis+software%22">Data analysis software</searchLink><br /><searchLink fieldCode="DE" term="%22Genotypes%22">Genotypes</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+utilization%22">Drug utilization</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Contemporary antiretroviral therapy (ART) is well-tolerated, safe and has simple dosing schedules. Here we evaluate a clinic wide initiative that uses detailed ART reviews when switching highly treatment-experienced individuals with or without HIV viremia to new regimens. We hypothesized that viral suppression post-switch would be maintained or improved. Persons who had a comprehensive ART review performed between March 2016 and December 2020 for optimization or virologic failure in an urban HIV clinic were included. Primary outcome was viral suppression at 6 months post-switch, and secondary outcomes included sustained viral suppression at 2 years, ART regimen characteristics and metabolic-associated changes. In patients with suppressed HIV-RNA who optimized therapy, 43 (96%) of 45 remained suppressed at 6 months. Among people switching for virologic failure, 16 (84%) of 19 achieved viral suppression at 6 months. Two years post-switch, 44 (88%) of 50 people were still in care on the optimized regimen and had viral suppression. Multiple different ART regimen characteristics improved as well. The use of ART reviews to assist in regimen recommendations for people with HIV who are highly treatment experienced is safe and effective. HIV clinicians should consider using detailed ART reviews in highly treatment-experienced individuals to facilitate optimization and record this critical medical history. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of AIDS Care is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=189061864 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/09540121.2025.2566862 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1883 Subjects: – SubjectFull: Documentation Type: general – SubjectFull: Medical protocols Type: general – SubjectFull: Antiretroviral agents Type: general – SubjectFull: Data analysis Type: general – SubjectFull: Creatinine Type: general – SubjectFull: Drug resistance in microorganisms Type: general – SubjectFull: Salvage therapy Type: general – SubjectFull: Body weight Type: general – SubjectFull: HIV infections Type: general – SubjectFull: Retrospective studies Type: general – SubjectFull: Descriptive statistics Type: general – SubjectFull: Chi-squared test Type: general – SubjectFull: Mann Whitney U Test Type: general – SubjectFull: DNA Type: general – SubjectFull: Highly active antiretroviral therapy Type: general – SubjectFull: Workflow Type: general – SubjectFull: Low density lipoproteins Type: general – SubjectFull: Medical records Type: general – SubjectFull: Acquisition of data Type: general – SubjectFull: Electronic health records Type: general – SubjectFull: Alanine aminotransferase Type: general – SubjectFull: Social support Type: general – SubjectFull: Quality assurance Type: general – SubjectFull: Data analysis software Type: general – SubjectFull: Genotypes Type: general – SubjectFull: Drug utilization Type: general Titles: – TitleFull: The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hawkins, Kellie L. – PersonEntity: Name: NameFull: Hojat, Leila S. – PersonEntity: Name: NameFull: Hicks, Carrie – PersonEntity: Name: NameFull: McLees, Margaret P. – PersonEntity: Name: NameFull: Rowan, Sarah – PersonEntity: Name: NameFull: Burman, William J. – PersonEntity: Name: NameFull: Gardner, Edward M. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09540121 Numbering: – Type: volume Value: 37 – Type: issue Value: 11 Titles: – TitleFull: AIDS Care Type: main |
| ResultId | 1 |